Skip to main content

Advertisement

Log in

Synthesis of myricetin derivatives and evaluation of their hypoglycemic activities

  • Original Research
  • Published:
Medicinal Chemistry Research Aims and scope Submit manuscript

Abstract

Myricetin is a common plant-derived flavonoid and exhibits a wide range of activities. However, myricetin also exhibits substantial limitations, such as its poor water-solubility and low stability in body when it was administrated orally. To solve these problems, a series of myricetin derivatives with different disaccharide groups were designed, synthesized and evaluated their hypoglycemic activities. All synthesized compounds displayed significant α-glucosidase inhibitory activity in comparison with acarbose in vitro, which indicated that myricetin derivatives with different disaccharide groups had good hypoglycemic activity and could be further developed as hypoglycemic drugs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Scheme 1
Scheme 2

Similar content being viewed by others

Data availability

All data generated or analysed during this study are included in this published article and its supplementary information files.

References

  1. Salvamani S, Gunasekaran B, Shaharuddin NA, Ahmad SA, Shukor MY. Antiartherosclerotic effects of plant flavonoids. Biomed Res Int. 2014;2014:1–11. https://doi.org/10.1155/2014/480258

    Article  Google Scholar 

  2. Lee DH, Lee CS. Flavonoid myricetin inhibits TNF-α-stimulated production of inflammatory mediators by suppressing the Akt, mTOR and NF-κB pathways in human keratinocytes. Eur J Pharm. 2016;784:164–72. https://doi.org/10.1016/j.ejphar.2016.05.025

    Article  Google Scholar 

  3. Cho BO, Hong HY, Sang HP, Byun EB, Ha HY, Jang SI. Anti-inflammatory activity of myricetin from Diospyros through suppression of NF-κB and STAT1 activation and Nrf2-mediated HO-1 induction in lipopolysaccharide-stimulated RAW264.7 macrophages. Biosci Biotech Bioch. 2016;80:1520–30. https://doi.org/10.1080/09168451.2016.1171697

    Article  Google Scholar 

  4. Tong Y, Zhou XM, Wang SJ, Yang Y, Cao YL. Analgesic activity of myricetin isolated from Myrica rubra Sieb. et Zucc. leaves. Arch Pharm Res. 2009;32:527–33. https://doi.org/10.1007/s12272-009-1408-6

    Article  Google Scholar 

  5. Kwon O, Eck P, Chen S, Corpe CP, Lee JH, Kruhlak M, et al. Inhibition of the intestinal glucose transporter GLUT2 by flavonoids. FASEB J. 2007;21:366–77. https://doi.org/10.1096/fj.06-6620com

    Article  Google Scholar 

  6. Strobel P, Allard C, Perez-Acle T, Calderon R, Aldunate R, Leighton F. Myricetin, quercetin and catechin-gallate inhibit glucose uptake in isolated rat adipocytes. Biochem J. 2005;386:471478 https://doi.org/10.1042/BJ20040703

    Article  Google Scholar 

  7. Ong KC, Khoo HE. Insulinomimetic effects of myricetin on lipogenesis and glucose transport in rat adipocytes but not glucose transport translocation. Biochem Pharm. 1996;51:423–9. https://doi.org/10.1016/S0024-3205(00)00758-X

    Article  Google Scholar 

  8. Manaharan T, Ming CH, Palanisamy UD. Syzygium aqueum leaf extract and its bioactive compounds enhances preadipocyte differentiation and 2-NBDG uptake in 3T3-L1 cells. Food Chem. 2013;136:354–63. https://doi.org/10.1016/j.foodchem.2012.08.056

    Article  Google Scholar 

  9. Kandasamy N, Ashokkumar N. Protective effect of bioflavonoid myricetin enhances carbohydrate metabolic enzymes and insulin signaling molecules in streptozotocin-cadmium induced diabetic nephrotoxic rats. Toxicol Appl Pharm. 2014;279:173–85. https://doi.org/10.1016/j.taap.2014.05.014

    Article  Google Scholar 

  10. Ong KC, Khoo HE. Effects of myricetin on glycemia and glycogen metabolism in diabetic rats. Life Sci. 2000;67:1695–705. https://doi.org/10.1016/S0024-3205(00)00758-X

    Article  Google Scholar 

  11. Lin CY, Ni CC, Yin MC, Lii CK. Flavonoids protect pancreatic beta-cells from cytokines mediated apoptosis through the activation of PI3-kinase pathway. Cytokine. 2012;59:65–71. https://doi.org/10.1016/j.cyto.2012.04.011

    Article  Google Scholar 

  12. Ying L, Zheng X, Yi X, Liu C, Kong D, Zhang J, et al. Myricetin: a potent approach for the treatment of type 2 diabetes as a natural class B GPCR agonist. FASEB J. 2017;31:2603–11. https://doi.org/10.1096/fj.201601339R

    Article  Google Scholar 

  13. Castillo-Muñoz N, Gómez-Alonso S, García-Aomero E, Gómez MV, Velders AH, Hermosín-Gutiérrez I. Flavonol 3-O-Glycosides Series of Vitis vinifera Cv. Petit Verdot Red Wine Grapes. J Agric Food Chem. 2007;55:992–1002. https://doi.org/10.1021/jf802863g

    Article  Google Scholar 

  14. Arif H, Sohail A, Farhan M, Rehman AA, Ahmad A, Hadi SM. Flavonoids-Induced Redox Cycling of Copper Ions Leads to Generation of Reactive Oxygen Species: A Potential Role in Cancer Chemoprevention. Int J Biol Macromol. 2017;106:569–78. https://doi.org/10.1016/j.ijbiomac.2017.08.049

    Article  Google Scholar 

  15. Silva LN, Da HG, Soares TA, Bojer MS, Ingmer H, Macedo AJ, et al. Myricetin protects Galleria mellonella against Staphylococcus aureus infection and inhibits multiple virulence factors. Sci Rep. 2017;7:2823–38. https://doi.org/10.1038/s41598-017-02712-1

    Article  Google Scholar 

  16. Li Y, Cui SX, Sun SY, Shi WN, Qu XJ. Chemoprevention of intestinal tumorigenesis by the natural dietary flavonoid myricetin in APC Min/+ mice. Oncotarget. 2016;7:60446–60. https://doi.org/10.18632/oncotarget.11108

    Article  Google Scholar 

  17. Yamauchi K, Mitsunaga T, Batubara I. Synthesis of quercetin glycosides and their melanogenesis stimulatory activity in B16 melanoma cells. Bio Med Chem. 2014;22:937–44. https://doi.org/10.1016/j.bmc.2013.12.062

    Article  Google Scholar 

  18. Zhu SF, Yang C, Zhang L, Wang SX, Ma MX, Zhao JC, et al. Development of M10, myricetin-3-O-β-D-lactose sodium salt, a derivative of myricetin as a potent agent of anti-chronic colonic inflammation. Eur J Med Chem. 2019;174:9–15. https://doi.org/10.1016/j.ejmech.2019.04.031

    Article  Google Scholar 

  19. Magnusson JO. Galabiosyl donors; efficient synthesis from 1,2,3,4, 6-penta-O-acetyl-beta-D-galactopyranose. Cheminform. 2000;329:49–55. https://doi.org/10.1016/S0008-6215(00)00154-3

    Article  Google Scholar 

Download references

Author contributions

FL, CY, and LZ synthesized compounds and contributed to the design and characterization of compounds. FL and WL performed to the preparation of the manuscript. FL and CY performed the biological assay. WL supervised all phases of the study. All authors read and approved the article.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Feng Li or Wenbao Li.

Ethics declarations

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Li, F., Yang, C., Zhang, L. et al. Synthesis of myricetin derivatives and evaluation of their hypoglycemic activities. Med Chem Res 32, 76–84 (2023). https://doi.org/10.1007/s00044-022-02992-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00044-022-02992-x

Keywords

Navigation